Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Immunohistochemistry [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-79424 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Bone SialoProtein Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Reconstitute with 0.2 mL of distilled water to yield a concentration of 500 µg/mL.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µg
- Concentration
- 500 µg/mL
- Storage
- -20°C
Submitted references Impact of Marine-Based Biomaterials on the Immunoregulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells: Potential Use of Fish Collagen in Bone Tissue Engineering.
Liu C, Sun J
ACS omega 2020 Nov 3;5(43):28360-28368
ACS omega 2020 Nov 3;5(43):28360-28368
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry analysis of Bone SialoProtein on paraffin-embedded human Osteosarcoma tissue. Sample was incubated with Bone SialoProtein polyclonal antibody (Product# PA5-79424).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 4 Expression of TSG-6 in BMSCs and the effect of TSG-6 siRNA on the osteogenic differentiation of BMSCs. (A) mRNA expression levels of TSG-6 in BMSCs, BMSCs treated with transfection reagents only (BMSCs+TR), BMSCs transfected with scrambled siRNA (BMSCs+SS), and BMSCs transfected with TSG-6 siRNA (TSG-6-siRNA-BMSCs) were determined by real-time RT-PCR. Results are presented as the mean +- standard deviation of three independent experiments. * p < 0.05 compared with the BMSC group. (B) TSG-6 concentrations measured in the supernatants from BMSCs, BMSCs treated with HFC (BMSCs+HFC), TSG-6-siRNA-BMSCs treated with HFC (TSG-6-siRNA-BMSCs+HFC), and BMSCs transfected with scrambled siRNA (BMSCs+SS) with data given as mean +- SD ( n = 3). * p < 0.05 compared with the BMSC group. (C) Western blot analysis of RUNX2, OCN, and BSP from cell lysates of the BMSCs, BMSCs treated with HFC (BMSCs+HFC), TSG-6-siRNA-BMSCs treated with HFC (TSG-6-siRNA-BMSCs+HFC), and BMSCs transfected with scrambled siRNA (BMSCs+SS). (D-F) Densiometric analyses of western blot images. * p < 0.05, n = 3.